Navigation Links
Oncothyreon's PX-478 is effective in preclinical model of human lung cancer
Date:2/25/2008

ovel small molecule compound that inhibits the activity of hypoxia inducible factor (HIF)-1 alpha, a transcription factor that controls the expression of a number of genes important for growth and survival of cancer cells. Genes regulated by HIF-1 alpha contribute to diverse functions including new blood vessel growth (angiogenesis), use of glucose for energy, and protection against apoptosis (programmed cell death).

Preclinical data have demonstrated that PX-478 can induce apoptosis in experimental tumor models, as well as the down-regulation of factors which control angiogenesis, such as vascular endothelial growth factor (VEGF). PX-478 is effective when delivered orally in animal models, and has shown marked tumor regressions and growth inhibition in model systems across a range of cancers, including lung, ovarian, renal, prostatic, colon, pancreatic, and breast cancer. The wide variety of models that show sensitivity to PX-478 represents a large potential market for this product candidate. The ability to combine PX-478 with radiation therapy may further expand the opportunities for this novel compound.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit http://www.oncothyreon.com.

Forward-Looking Statements

In order to provide Oncothyreon's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward looking, including statements related to the ongoing Phase 1 trial of PX-478; the therapeutic and commercial potential of PX-478; and future clinical development plans for PX-478. These forward-looking s
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Phase III Trial Finds Pharmaxis Bronchitol Effective
2. New nanoparticle vaccine is more effective but less expensive
3. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
4. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
5. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
6. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
7. Free White Paper Available for Clinical Laboratory Managers: Effectively Isolating Anaerobic Bacteria
8. DNA sensors found to be an effective artificial nose
9. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
10. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
11. Genmab Announces Encouraging Preclinical Data for ofatumumab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SC (PRWEB) October 22, 2014 ... of its cardiovascular pharmacogenetics menu, which enables healthcare ... outcomes. With PCLS’s evidence-based results, healthcare providers ... and optimize their therapy, while minimizing risks for ... the U.S., according to the FDA [1] more ...
(Date:10/22/2014)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... Oral Amphotericin B program.  The company recently announced ... work involving samples from HIV/AIDS patients exposed to ... clinical studies and regulatory filings to move forward ... approximately $700,000 of funding and technological advice from ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... Convey Computer , the leader in ... State University won first place in the 2014 ... the team’s solution achieved the highest overall performance in ... place finisher. , Experts from all segments of the ... challenge, using a variety of design tools, hardware and ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... 18 W. R. Grace & Co. (NYSE: ... Court for the District of Delaware of the previously announced ... as of September 13, 2010 pursuant to which W. R. ... & Co., will purchase Synthetech, Inc. (OTC Bulletin Board: ...
... work done at the Department of Energy,s Oak Ridge ... unexpected magnetism between two dissimilar materials. The results, ... for the design of future electronic devices for computations ... Materials Science and Technology Division. The work was performed ...
... Reportlinker.com announces that a new market ... Global Automated And Rapid ... http://www.reportlinker.com/p092467/Global-Automated-And-Rapid-Microbiological-Tests-Industry.html This report analyzes ... Microbiological Tests in US$ Million by the ...
Cached Biology Technology:Synthetech Announces Bankruptcy Court Approval of Merger With W. R. Grace Subsidiary 2Synthetech Announces Bankruptcy Court Approval of Merger With W. R. Grace Subsidiary 3ORNL theorist part of team that discovers unexpected magnetism 2Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 2Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 3Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 4Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 5Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 6Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 7Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 8Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 9Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 10Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 11Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 12Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 13Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 14Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 15Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 16Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 17Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 18Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 19Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 20Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 21Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 22Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 23Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 24Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 25
(Date:10/17/2014)... release is available in German . ... a very few drugs. When treating overdoses, doctors are often ... especially difficult if there is a combination of drugs involved. ... and accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux ... to find an answer to this question. "The task was ...
(Date:10/16/2014)... have challenged conventional thinking on how the bowel lining ... for how bowel cancer starts. , The researchers produced ... regenerating the ,crypts, that are a feature of the ... in bowel cancer development, a controversial finding as scientists ... Using 3D imaging technologies, Dr Chin Wee Tan and ...
(Date:10/16/2014)... 16, 2014 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... including Wocket™, the Smart Wallet, at the 13 th ... a leading global conference on the intersection of technology ... Mark Anderson , founder and publisher of the Strategic ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3Cryptic clues drive new theory of bowel cancer development 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
... in some regions and increasing global demand for high ... water globally. This was the main conclusion of a ... Education. The special report follows a strategic workshop ... rules of international trade" held on 25th - 26th ...
... at the Genome Institute of Singapore (GIS) have, for ... comes with a guarantee on its reliability when reconstructing ... streamlined process for reconstructing and studying genomic sequences. ... of Computational and Mathematical Biology at the GIS, was ...
... fish have a greater capacity to cope with rising sea ... The discovery, by researchers at the ARC Centre of ... sheds a ray of hope amid the rising concern over ... levels of global warming expected to occur by the end ...
Cached Biology News:Experts call on governments, industries and the water and trade research communities 2Researchers at GIS develop systematic approach for accurate DNA sequence reconstruction 2When the heat's on, fish can cope 2When the heat's on, fish can cope 3
...
p27 rabbit polyclonal antibody...
... Rabbit polyclonal to Ki67 - Proliferation Marker, ... cell cycle related nuclear protein, expressed by ... active cell cycle (G1, S, G2 and ... (G0) cells. Ki67 antibodies are useful in ...
UBC13 Antibody...
Biology Products: